Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales - adhoc - Börsennachrichten
Kuros Biosciences AG Key word Quarter ResultsRegulatory Approval Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales 24Apr2024 0700 CETCEST Release of an ad